Progression-free survival ratio as end point for phase II trials in advanced solid tumors
- PMID: 21464417
- DOI: 10.1200/JCO.2010.34.0380
Progression-free survival ratio as end point for phase II trials in advanced solid tumors
Comment on
-
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.J Clin Oncol. 2010 Nov 20;28(33):4877-83. doi: 10.1200/JCO.2009.26.5983. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921468
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
